Gaush Meditech

Gaush Meditech R&D per Employee

The R&D Spending per Employee of Gaush Meditech (2407.HK) as of Nov 10, 2026 is 112,758.83 CNY. In the previous year, R&D Spending per Employee was 81,703.54 CNY — a change of 38.01% (higher).

R&D per Employee

112,758.83CNY

YoY

38.01%

Last updated:

R&D Spending per Employee of Gaush Meditech is 2025 112,758.83 CNY. R&D Spending per Employee of Gaush Meditech was 2024 81,703.54 CNY. It decreases by 38.01% higher compared to the previous year.

The Gaush Meditech R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
2,770.41 CNY
Jan 1, 2020
3,270.52 CNY
Jan 1, 2021
24,490.85 CNY
Jan 1, 2022
42,810.54 CNY
Jan 1, 2023
55,098.68 CNY
Jan 1, 2024
81,703.54 CNY
Jan 1, 2025
112,758.83 CNY
The Gaush Meditech R&D per Employee history
YEARR&D per EmployeeYoY
112,758.83CNY+38.01%
81,703.54CNY+48.29%
55,098.68CNY+28.70%
42,810.54CNY+74.80%
24,490.85CNY+648.84%
3,270.52CNY+18.05%
2,770.41CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gaush Meditech Stock analysis

What does Gaush Meditech do? Gaush Meditech Ltd. generates revenue through four business segments. The Proprietary Products segment develops and sells surgical equipment, intraocular lenses, and diagnostic and treatment devices for ophthalmic diseases, along with related software and consumables. The Distribution segment distributes branded ophthalmic medical devices and consumables. The Technical Services segment offers after-sales services including warranty, maintenance, and consumables support. The Others segment handles equipment leasing and intellectual property agency services. Products are used in treating conditions like cataracts, glaucoma, and pediatric ophthalmology across various medical specialties. The company's primary customers include hospitals, clinics, and medical institutions specializing in ophthalmology. These institutions purchase proprietary devices, branded consumables, and technical support services. The firm's focus on ophthalmic subspecialties ensures consistent demand for its products and services in the treatment of eye diseases. Revenue streams are diversified across product development, distribution, and post-sale services. The proprietary segment drives innovation with surgical equipment and lenses, while distribution and technical services provide steady income from established medical partners. Equipment leasing and IP services in the Others segment contribute to additional revenue without requiring direct product sales. Gaush Meditech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gaush Meditech stock

R&D Spending per Employee of Gaush Meditech is 112,758.83 CNY in 2025.

R&D Spending per Employee of Gaush Meditech changed from 81,703.54 CNY to 112,758.83 CNY, representing a 38.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Gaush Meditech since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Gaush Meditech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Gaush Meditech

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Gaush Meditech